The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis
Abstract
BACKGROUND.: The specific volatile organic compounds (VOCs) exhaled by lung cancer cells in the microenvironment are the source biomarkers of lung cancer and also serve as direct evidence that the diagnosis of lung cancer by breath is possible. However, to the authors' knowledge, few articles published to date have provided accurate VOCs in the microenvironment, thereby leading to different points of view with regard to searching for biomarkers in the breath from lung cancer patients In this article, an innovative pathologic analysis method of lung cancer and the early diagnosis of lung cancer at the cellular level were introduced for this purpose. METHODS.: Solid‐phase microextraction combined with gas chromatography is used as the detection system to determine the VOCs in the culture medium of several target cells, including different kinds of lung cancer cells, bronchial epithelial cells, tastebud cells, osteogenic cells, and lipocytes. As a result, each kind of cells has a unique chromatogram. There are 4 special VOCs that were found to exist in all culture mediums of lung cancer cells, which are the metabolic products of lung cancer cells and can be viewed as markers of lung cancer. RESULTS.: The authors were able to determine a correlation between VOCs in the metabolic products of lung cancer cells and VOCs in the breath of lung cancer patients, some of whom had stage I and II disease, and eventually hope to certify the biomarkers in the breath of lung cancer patients. CONCLUSIONS.: This research is significant and provides the basis for the noninvasive detection and the breath diagnosis of lung cancer using an electronic nose. Cancer 2007; 110:835–44. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Cited by
Amann, A., Costello, B. D. L., Miekisch, W., Schubert, J., Buszewski, B., Pleil, J., Ratcliffe, N., & Risby, T. (2014) · Journal of Breath Research · doi:10.1088/1752-7155/8/3/034001 · Cited by 804
Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013) · Chest · doi:10.1378/chest.12-2345 · Cited by 737
Metabolomics-based methods for early disease diagnostics
Gowda, G. N., Zhang, S., Gu, H., Asiago, V., Shanaiah, N., & Raftery, D. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.5.617 · Cited by 692
The scent of disease: volatile organic compounds of the human body related to disease and disorder
Shirasu, M., & Touhara, K. (2011) · Journal of Biochemistry · doi:10.1093/jb/mvr090 · Cited by 619
Noninvasive detection of lung cancer by analysis of exhaled breath
Bajtarevic, A., Ager, C., Pienz, M., Klieber, M., Schwarz, K., Ligor, M., Ligor, T., Filipiak, W., Denz, H., Fiegl, M., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-348 · Cited by 597
Nondestructive Sampling of Living Systems Using in Vivo Solid-Phase Microextraction
Ouyang, G., Vuckovic, D., & Pawliszyn, J. (2011) · Chemical Reviews · doi:10.1021/cr100203t · Cited by 426
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD
Dragonieri, S., Annema, J. T., Schot, R., van der Schee, M. P. C., Spanevello, A., Carratú, P., Resta, O., Rabe, K. F., & Sterk, P. J. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.08.008 · Cited by 407
The versatile use of exhaled volatile organic compounds in human health and disease
Boots, A. W., van Berkel, J. J. B. N., Dallinga, J. W., Smolinska, A., Wouters, E. F., & van Schooten, F. J. (2012) · Journal of Breath Research · doi:10.1088/1752-7155/6/2/027108 · Cited by 352
VOC breath biomarkers in lung cancer
Saalberg, Y., & Wolff, M. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.013 · Cited by 293
Hybrid Volatolomics and Disease Detection
Broza, Y. Y., Mochalski, P., Ruzsanyi, V., Amann, A., & Haick, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500153 · Cited by 290
Sensing Technologies for Detection of Acetone in Human Breath for Diabetes Diagnosis and Monitoring
Saasa, V., Malwela, T., Beukes, M., Mokgotho, M., Liu, C.-P., & Mwakikunga, B. (2018) · Diagnostics · doi:10.3390/diagnostics8010012 · Cited by 287
Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation
Broza, Y. Y., Vishinkin, R., Barash, O., Nakhleh, M. K., & Haick, H. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00317c · Cited by 276
Exhaled biomarkers in lung cancer
Horváth, I., Lázár, Z., Gyulai, N., Kollai, M., & Losonczy, G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00142508 · Cited by 268
Ligor, M., Ligor, T., Bajtarevic, A., Ager, C., Pienz, M., Klieber, M., Denz, H., Fiegl, M., Hilbe, W., Weiss, W., et al. (2009) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2009.133 · Cited by 262
Electronic nose: a non-invasive technology for breath analysis of diabetes and lung cancer patients
Behera, B., Joshi, R., Anil Vishnu, G. K., Bhalerao, S., & Pandya, H. J. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/aafc77 · Cited by 179
Binson, V. A., & Subramoniam, M. (2022) · Journal of Biomimetics, Biomaterials and Biomedical Engineering · doi:10.4028/p-dab04j · Cited by 14
Metadata
- Authors
- Chen, X., Xu, F., Wang, Y., Pan, Y., Lu, D., Wang, P., Ying, K., Chen, E., & Zhang, W.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-06-28
- Volume
- 110
- Issue
- 4
- Pages
- 835-844
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2007635507
- Cited by
- 251
- References
- 1
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.